These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 2381586)

  • 21. Development of an AIDS vaccine. Biological and ethical challenges.
    Graham BS; Karzon DT
    Infect Dis Clin North Am; 1990 Jun; 4(2):223-43. PubMed ID: 2188999
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunization of rhesus macaques with a polyvalent DNA prime/protein boost human immunodeficiency virus type 1 vaccine elicits protective antibody response against simian human immunodeficiency virus of R5 phenotype.
    Pal R; Kalyanaraman VS; Nair BC; Whitney S; Keen T; Hocker L; Hudacik L; Rose N; Mboudjeka I; Shen S; Wu-Chou TH; Montefiori D; Mascola J; Markham P; Lu S
    Virology; 2006 May; 348(2):341-53. PubMed ID: 16460776
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The antigenic structure of the HIV gp120 envelope glycoprotein.
    Wyatt R; Kwong PD; Desjardins E; Sweet RW; Robinson J; Hendrickson WA; Sodroski JG
    Nature; 1998 Jun; 393(6686):705-11. PubMed ID: 9641684
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prototype AIDS vaccine works in monkeys.
    J Pract Nurs; 1990 Mar; 40(1):6-7. PubMed ID: 2329537
    [No Abstract]   [Full Text] [Related]  

  • 25. Human immunodeficiency virus type 1 (HIV-1) gp120-specific antibodies in neonates receiving an HIV-1 recombinant gp120 vaccine.
    McFarland EJ; Borkowsky W; Fenton T; Wara D; McNamara J; Samson P; Kang M; Mofenson L; Cunningham C; Duliege AM; Sinangil F; Spector SA; Jimenez E; Bryson Y; Burchett S; Frenkel LM; Yogev R; Gigliotti F; Luzuriaga K; Livingston RA;
    J Infect Dis; 2001 Nov; 184(10):1331-5. PubMed ID: 11679925
    [TBL] [Abstract][Full Text] [Related]  

  • 26. AIDS vaccine shown to be safe in subjects.
    AAOHN J; 1989 Nov; 37(11):485. PubMed ID: 2684193
    [No Abstract]   [Full Text] [Related]  

  • 27. Induction of a MHC class I-restricted, CD8 positive cytolytic T-cell response by chimeric HIV-1 virus-like particles in vivo: implications on HIV vaccine development.
    Wagner R; Deml L; Schirmbeck R; Reimann J; Wolf H
    Behring Inst Mitt; 1994 Dec; (95):23-34. PubMed ID: 7755506
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Definitive toxicology and biodistribution study of a polyvalent DNA prime/protein boost human immunodeficiency virus type 1 (HIV-1) vaccine in rabbits.
    Pal R; Yu Q; Wang S; Kalyanaraman VS; Nair BC; Hudacik L; Whitney S; Keen T; Hung CL; Hocker L; Kennedy JS; Markham P; Lu S
    Vaccine; 2006 Feb; 24(8):1225-34. PubMed ID: 16219399
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Randomized, double-blind, placebo-controlled efficacy trial of a bivalent recombinant glycoprotein 120 HIV-1 vaccine among injection drug users in Bangkok, Thailand.
    Pitisuttithum P; Gilbert P; Gurwith M; Heyward W; Martin M; van Griensven F; Hu D; Tappero JW; Choopanya K;
    J Infect Dis; 2006 Dec; 194(12):1661-71. PubMed ID: 17109337
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of new vaccines for AIDS.
    Garrison L; Clements ML
    Compr Ther; 1989 Jul; 15(7):47-55. PubMed ID: 2670404
    [No Abstract]   [Full Text] [Related]  

  • 31. AIDS and immune dysfunction. Alternative etiologic mechanisms.
    del Guercio P
    Contrib Microbiol Immunol; 1989; 11():289-304. PubMed ID: 2573482
    [No Abstract]   [Full Text] [Related]  

  • 32. Stable expression of the transfected HIV-1 env gene in a human B cell line: characterization of gp120-expressing clones and immunobiological studies.
    Ahmad A; Ladha A; Cohen EA; Menezes J
    Virology; 1993 Feb; 192(2):447-57. PubMed ID: 8421893
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Public health. AIDS vaccine still alive as booster after second failure in Thailand.
    Cohen J
    Science; 2003 Nov; 302(5649):1309-10. PubMed ID: 14631004
    [No Abstract]   [Full Text] [Related]  

  • 34. [Pharmacologic treatment of acquired immunodeficiency syndrome].
    Clotet B; Jou A
    Med Clin (Barc); 1989 Sep; 93(9):344-7. PubMed ID: 2691783
    [No Abstract]   [Full Text] [Related]  

  • 35. AIDS research. Debate begins over new vaccine trials.
    Cohen J
    Science; 2001 Sep; 293(5537):1973. PubMed ID: 11557856
    [No Abstract]   [Full Text] [Related]  

  • 36. AIDS vaccine: hope and despair.
    Lancet; 1990 Dec 22-29; 336(8730):1545-6. PubMed ID: 1979371
    [No Abstract]   [Full Text] [Related]  

  • 37. 19th annual UCLA symposium: HIV and AIDS: pathogenesis, therapy and vaccine. Abstracts.
    J Cell Biochem Suppl; 1990; 14D():77-181. PubMed ID: 2381232
    [No Abstract]   [Full Text] [Related]  

  • 38. Can an AIDS vaccine be developed?
    Levy JA
    Transfus Med Rev; 1988 Dec; 2(4):264-71. PubMed ID: 2856529
    [No Abstract]   [Full Text] [Related]  

  • 39. New hope on the AIDS vaccine front.
    Marx JL
    Science; 1989 Jun; 244(4910):1254, 1256. PubMed ID: 2734608
    [No Abstract]   [Full Text] [Related]  

  • 40. Approaches to HIV vaccine design.
    Bolognesi DP
    Trends Biotechnol; 1990 Feb; 8(2):40-5. PubMed ID: 1366496
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.